2024-04-18 09:09:02 ET
Rentokil Initial plc (RTO)
Q1 2024 Sales/Trading Statement Call
April 18, 2024 04:30 AM ET
Company Participants
Andy Ransom - Chief Executive Officer
Stuart Ingall-Tombs - Chief Financial Officer
Conference Call Participants
Annelies Vermeulen - Morgan Stanley
Suhasini Varanasi - Goldman Sachs
James Rose - Barclays
Sylvia Barker - JPMorgan
Nicole Manion - UBS
Allen Wells - Jefferies
Presentation
Operator
Welcome everyone, and thank you for standing by for the Rentokil Initial First Quarter 2024 Results Conference Call. With us today are Chief Executive, Andy Ransom and CFO, Stuart Ingall-Tombs.
I will now turn the call over to Andy. Please go ahead.
Andy Ransom
Thank you very much and good morning, everyone. I'm going to make some brief opening remarks and then Stu and I will be very happy to take any questions. I will refer to a few slides that are available on the Investors section of our website. The presentation obviously, includes a cautionary statement on Slide 2 regarding forward-looking statements.
We've had a positive overall start to the year with Group revenue up by 4.9% to £1.29 billion. Organic growth for the group was 3.1%. And in North America our RIGHT WAY 2 plan has delivered a stabilizing performance with organic growth of 1.5%. Europe, the Group's second largest region delivered another strong performance, with organic growth of 6.2% in the quarter. The UK and Sub-Saharan Africa region contributed 4.1% organic growth against an ongoing challenging backdrop. Asia and MENAT was up by 4.3%, while our Pacific region delivered organic growth of 7.3%....
Read the full article on Seeking Alpha
For further details see:
Rentokil Initial plc (RTO) Q1 2024 Sales/Trading Statement Call Transcript